HR Execs on the Move

Wellteq

www.wellteq.co

 
Wellteq is creating the future of precision wellness through a digital wellbeing ecosystem taking users from point of prevention through to point of care. Delivered into the corporate health and insurance sector to drive user engagement through a personalised wellness journey. wellteq uses a range of data types from wearable devices, sensors, biomarkers and user-generated data that, in combination with machine learning and artificial intelligence enables individual-level insights into Stress, Fatigue, Sleep Quality, Cognitive Function and Activity levels. Behavioural science and content targeting use biometric and behavioural analytics to deliver personalised wellness insights and practical recommendations to build engagement, agency ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.wellteq.co
  • 580 Hornby Street Suite 880
    Vancouver, BC USA V6C 3B6
  • Phone: 647.256.1986

Executives

Name Title Contact Details
Olly Bridge
 Chief Growth Officer Profile

Similar Companies

Clarendon Memorial Hospital

Clarendon Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Manning, SC. To find more information about Clarendon Memorial Hospital, please visit www.clarendonhealth.com

Cayce's Pharmacy

Cayce's Pharmacy is a Hopkinsville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Granite MEDSystems Americas

Granite MEDSystems Americas is a Mequon, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PreferredOne

At PreferredOne, our name says it all. You, our valued members, are our preferred ones. Everything we do is for one purpose - to make your experience the best it can be.   We offer individual health insurance, family medical plans and group health insurance to fit your needs and budget, plus wellness programs to help you stay healthy. We are known for outstanding customer service and for paying claims promptly, and our representatives are available to answer any questions you have about health care coverage.   PreferredOne has served our Minnesota and upper Midwest members for almost 30 years.

Neuralstem

Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic